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mRNA:	  messenger	  ribonucleic	  acid	  
MicroRNA/miRNA:	  micro	  ribonucleic	  acid	  
CLIP-­‐Seq:	  cross	  linking	  and	  immunoprecipitation	  sequencing	  
Degradome-­‐Seq:	  degradome	  sequencing	  
UTR:	  untranslated	  region	  
miRISCs:	  miRNA-­‐induced	  silencing	  complexes	  
TF:	  transcription	  factor	  
SILAC:	  stable	  isotope	  labeling	  by	  amino	  acids	  in	  cell	  culture	  
PRISM:	  proteomic	  investigation	  strategy	  for	  mammals	  
IS:	  interaction	  score	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Summary	  
MicroRNAs	   (miRNAs)	   regulate	   gene	   expression	   through	   translational	   repression	   and	   RNA	  
degradation.	   Recently	   developed	   high-­‐throughput	   proteomic	   methods	   measure	   gene	  
expression	   changes	   at	   protein	   levels,	   and	   therefore	   can	   reveal	   the	   direct	   effects	   of	  miRNAs’	  
translational	   repression.	   Here,	   we	   present	   a	   web	   server,	   ProteoMirExpress	   that	   integrates	  
proteomic	  and	  mRNA	  expression	  data	  together	  to	   infer	  miRNA-­‐centered	  regulatory	  networks.	  
With	  both	  high	  throughput	  data	  from	  the	  users,	  ProteoMirExpress	  is	  able	  to	  discover	  not	  only	  
miRNA	   targets	   that	  have	  mRNA	  decreased,	  but	  also	   subgroups	  of	   targets	  whose	  proteins	  are	  
suppressed	   but	   mRNAs	   are	   not	   significantly	   changed	   or	   whose	   mRNAs	   are	   decreased	   but	  
proteins	  are	  not	   significantly	   changed,	  which	  were	  usually	   ignored	  by	  most	   current	  methods.	  
Furthermore,	   both	   direct	   and	   indirect	   targets	   of	   miRNAs	   can	   be	   detected.	   Therefore	  
ProteoMirExpress	  provides	  more	  comprehensive	  miRNA-­‐centered	  regulatory	  networks.	  We	  use	  
several	  published	  data	  to	  assess	  the	  quality	  of	  our	  inferred	  networks	  and	  prove	  the	  value	  of	  our	  
server.	   ProteoMirExpress	   is	   available	   at	   http://jjwanglab.org/ProteoMirExpress,	   with	   free	  
access	  to	  academic	  users.	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Introduction	  
MicroRNAs	   (miRNAs)	   are	   small	   non-­‐coding	   RNAs	   that	   regulate	   gene	   expression	   by	   either	  
causing	  translation	  inhibition	  or	  mRNA	  decay	  (1).	  Posttranscriptional	  regulation	  by	  miRNA	  is	  an	  
important	   level	   of	   the	   complex	   gene	   regulatory	   network	   and	   it	   controls	   a	   wide	   range	   of	  
biological	  processes.	  Deregulation	  of	  miRNAs	  expression	  can	  lead	  to	  various	  diseases,	  including	  
many	   human	   cancers	   (2).	   Therefore,	   understanding	   the	   regulatory	   networks	   of	   miRNAs	   in	  
different	   biological	   processes	   is	   crucial	   to	   unraveling	   their	   functional	   importance	   and	   to	  
providing	  a	  pool	  of	  targets	  for	  medical	  therapies.	   	  
Several	   approaches	   have	   been	   proposed	   to	   predict	   miRNA’s	   targets	   and	   to	   construct	  
miRNA-­‐centered	   regulatory	   networks.	   Computational	   approaches	   include	   miRNA	   target	  
prediction	  based	  on	  binding	  energy	  of	  miRNA-­‐mRNA	  interactions	  (3,	  4)	  and	  on	  the	  evolutionary	  
conservation	   of	   the	   seed	   regions	   (5-­‐7).	   Experimental	   approaches	   include	   identification	   of	  
destabilized	  mRNAs	  in	  the	  presence	  of	  a	  miRNA,	  or	  high-­‐throughput	  methods	  to	  detect	  mRNAs	  
bound	  by	  argonaute	  proteins	  and	  miRNA	  cleavage	  sites	  (8).	  Databases,	  such	  as	  MiRecords	  (9)	  
and	   TarBase	   (10),	   collect	   experimentally	   validated	   miRNA	   targets	   and	   starBase	   (8)	   collects	  
miRNA-­‐mRNA	  interaction	  maps	  from	  argonaute	  CLIP-­‐Seq	  and	  Degradome-­‐Seq	  data.	   	  
The	   anti-­‐correlation	   between	   the	   miRNA	   and	   their	   targets	   has	   been	   widely	   used	   to	   infer	  
miRNA-­‐target	   relationship.	   Several	  web	   servers	   have	   been	   developed	   to	   infer	  miRNA	   targets	  
based	  on	  the	  expression	  profiles	  of	  miRNAs	  and	  mRNAs	  from	  the	  same	  set	  of	  biological	  samples	  
(11-­‐16).	   For	   example,	   Generative	   model	   for	   miRNA	   regulation	   (GenMir++	   )	   uses	   a	   Bayesian	  
model	  to	  predict	  miRNA	  targets	  based	  on	  both	  target	  genes’	  3’	  UTR	  region	  sequence	  features	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and	   the	   correlation	   between	   expressions	   of	   miRNA	   and	   its	   targets	   (15).	   When	   miRNA	  
expression	  data	  is	  not	  available,	  active	  miRNA	  and	  its	  targets	  can	  be	  inferred	  by	  the	  enrichment	  
of	   its	   recognized	  motifs	   in	   the	   3’	   UTRs	   of	   suppressed	   genes	   in	   a	   biological	   state	   or	   process	  
(17-­‐20).	   Moreover,	   The	   condition-­‐specific	   mRNA-­‐miRNA	   network	   integrator	   (mirConnX)	   uses	  
transcription	   factor	   (TF)	   binding	   in	   the	   promoter	   region	   of	   miRNAs,	   as	   well	   as	   mRNA,	   to	  
construct	  transcriptional-­‐posttranscriptional	  regulatory	  network	  (21).	  Besides,	  miRNA	  function	  
can	  also	  be	  annotated	  by	   its	   target	  genes’	  enrichments	   in	  biological	  pathways,	  gene	  ontology	  
(GO)	  or	  diseases	  (11,	  22-­‐24).	   	  
Despite	  the	  great	  success	  of	  these	  methods,	  none	  of	  them	  consider	  the	  effects	  of	  a	  miRNA	  on	  
target	  gene’s	  output	  at	  both	  mRNA	  and	  protein	   levels.	   In	  addition	  to	  destabilization	  of	  mRNA	  
product,	  translational	  repression	  has	  been	  proposed	  to	  be	  another	  major	  mechanism	  of	  miRNA	  
regulation.	  Many	  examples	  have	  shown	  that	  miRNA	   is	  able	   to	  decrease	  protein	   level	  without	  
changing	  mRNA	  abundance	  (25-­‐27).	  It	  is	  considered	  that	  when	  the	  mature	  miRNA	  pairs	  with	  its	  
target	  perfectly,	  argonaute	  protein’s	  endonucleolytic	  active	  site	  will	  cleave	  the	  target	  mRNA’s	  
nucleotides	   that	   pair	   with	   bases	   10	   and	   11	   of	   the	   miRNA	   guide	   strand	   (1).	   In	   the	   cases	   of	  
non-­‐perfect	  pairing,	  or	  argonaute	  protein	   lacking	  of	  endonucleolytic	  activity,	  miRNAs	  regulate	  
genes	  through	  translation	  repression	  (1,	  28).	  However,	  recent	  study	  by	  Brodersen	  et	  al.	  found	  
that	   translational	   repression	   happened	   irrespective	   of	   the	   degree	   of	   complementarity	   or	  
location	  of	  target	  sites	  within	  mRNAs	  (29).	  Complete	  complementary	  paring	  miRNA	  may	  engage	  
in	   both	   mRNA	   cleavage	   and	   translational	   repression,	   and	   consequentially	   leads	   to	   protein	  
product	  decrease.	  Several	  models	  have	  been	  suggested	  to	  describe	  the	  translation	  repression	  
mechanism,	  including	  competition	  between	  miRNA-­‐induced	  silencing	  complexes	  (miRISCs)	  and	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elF4E	  gene	  for	  binding	  to	  the	  mRNA	  5’	  cap	  structure,	  deadenylation	  of	  the	  mRNA	  tail,	  ribosome	  
drop-­‐off	  and	  reduced	  translation	  elongation	  (1).	  Two	  recent	  papers	  reported	  that	  miRNA	  first	  
inhibited	  translation	  initiation	  and	  then	  induced	  mRNA	  deadenylation	  and	  decay	  (30,	  31).	  Even	  
though	  most	  of	  the	  miRNA	  targets	  undergo	  translational	  repression	  followed	  by	  decay,	  there	  is	  
a	   subgroup	  of	   targets	   primarily	   regulated	  by	   translation	   repression	  without	   significant	  mRNA	  
decay	  (30).	  It	  is	  still	  unclear	  why	  some	  target	  mRNAs	  are	  degraded	  while	  others	  are	  not.	   	  
Due	   to	   different	   mechanisms	   of	   miRNA	   regulation,	   its	   targets	   can	   either	   be	   translationally	  
repressed	  without	   significant	  decrease	   in	  mRNA	  abundance,	  or	   translationally	   repressed	  with	  
concordant	  decrease	  in	  mRNA	  abundance,	  or	  significantly	  decreased	  in	  mRNA	  abundance	  with	  
little	  protein	  changes	  at	  a	  certain	  time	  point	  (28,	  32,	  33).	  Current	  methods	  that	  use	  only	  mRNA	  
abundance	   to	   study	  miRNA	   regulatory	   effect	  may	  miss	  many	   targets	   that	   are	   suppressed	   at	  
protein	  level	  but	  without	  detectable	  mRNA	  changes,	  or	  overestimate	  miRNA’s	  effect	  on	  targets	  
that	  do	  not	  have	  detectable	  changes	  at	  protein	  level	  but	  with	  decreases	  in	  mRNA.	  These	  kinds	  
of	   false	   negative	   and/or	   false	   positive	   links	   between	   a	   miRNA	   and	   its	   targets	   may	   lead	   to	  
misunderstanding	  of	  a	  miRNA’s	  regulatory	  network,	  for	  example,	  when	  the	  miRNA’s	  target	  is	  a	  
TF.	  
Recently,	  the	  development	  of	  high-­‐throughput	  quantitative	  proteomic	  methods	  provides	  us	  the	  
opportunity	   to	   study	   the	   effect	   of	  miRNA	  on	   target’s	   protein	   outputs	   (32,	   34,	   35).	   However,	  
most	  of	  these	  studies	  restrict	  only	  on	  one	  or	  a	  few	  miRNAs	  or	  proteins.	  Furthermore,	  there	  is	  
no	   published	   tool	   for	   inferring	   miRNA-­‐centered	   regulatory	   network	   from	   high-­‐throughput	  
proteomic	  data.	  To	   fill	   the	  gap,	  we	  present	  here	  a	  new	  web	  server,	  ProteoMirExpress,	  which	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integrates	   mRNA	   and	   protein	   expression	   data	   to	   infer	   miRNA	   activities	   on	   their	   direct	   and	  
indirect	   targets	   in	   the	   absence	   or	   presence	   of	   miRNA	   expression	   data	   and	   construct	   the	  
regulatory	  networks	  controlled	  by	  miRNAs.	  We	  further	  use	  several	  published	  data	  to	  assess	  the	  
quality	   of	   our	   inferred	   networks.	   The	   assessment	   shows	   that	   ProteoMirExpressis	   is	   able	   to	  
effectively	  infer	  a	  miRNA-­‐centered	  regulatory	  network	  and	  identify	  subgroups	  of	  miRNA	  targets,	  
which	  are	  usually	  ignored	  by	  current	  available	  tools.	  
	  
Experimental	  Procedures	  
Web	  Server	  Integration	  and	  Implementation	  
ProteoMirExpress	   integrates	   mRNA	   and	   proteomic	   expression	   data	   together	   to	   infer	  
miRNA-­‐centered	  regulatory	  networks	  for	  a	  specific	  biological	  stage	  or	  process.	  The	  workflow	  of	  
ProteoMirExpress	   is	  briefly	  described	   in	  Figure	   1.	   It	  accepts	  both	  high	   throughput	  mRNA	  and	  
proteomic	  profiling	  data,	  and	  optionally	  the	  expression	  of	  miRNAs,	  preferably	  generated	  under	  
the	   same	  experiment	   condition	   (Figure	   1A).	   The	   server	  has	   the	   following	   functions:	  1)	   In	   the	  
absence	  of	  miRNA	  expression	   information,	  ProteoMirExpress	  will	  classify	  the	   input	  genes	   into	  
different	   groups	   according	   to	   their	   mRNA	   and	   protein	   levels,	   and	   infer	   miRNA	   networks	   by	  
calculating	  the	  overlaps	  between	  the	  potentially	  suppressed	  gene	  sets	  and	  the	  miRNA’s	  target	  
genes	   (Figure	   1B).	   2)	   In	   the	  presence	  of	  miRNA	  expression	   information,	   the	   targets	  of	   active	  
miRNA	  will	  be	   inferred	  by	   the	  anti-­‐correlation	  between	  miRNAs	  and	  their	  potential	   targets	   in	  
either	  mRNA	  or	  protein	  level,	  or	  both	  (Figure	  1B).	  The	  miRNA	  target	  genes	  are	  collected	  from	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multiple	   sources,	   including	  computational	  predictions,	  CLIP/Degradome-­‐seq	  and	  experimental	  
verifications	  (Figure	  1C).	  The	  inferred	  active	  miRNAs	  and	  their	  targets	  will	  be	  ranked	  according	  
to	   their	   p-­‐values	   (Figure	   1D).	   3)	   Indirect	   targets	   of	   miRNAs	   are	   also	   predicted	   by	   scanning	  
suppressed	  mRNAs’	  promoters	  with	  the	  binding	  site	  information	  of	  miRNA-­‐targeted	  TFs.	  4)	  The	  
miRNA-­‐centered	  regulatory	  network	  will	  be	  visualized	  on	  the	  web	  page	  (Figure	  1E).	  Users	  can	  
click	  on	  each	  miRNA	  to	  inspect	  all	  of	  its	  targets,	  as	  well	  as	  miRNA-­‐target	  interactions.	  
	  
Inputs	  
ProteoMirExpress	  takes	  inputs	  in	  tab-­‐delimited	  format	  containing	  high-­‐throughput	  protein	  and	  
mRNA	  expressions.	  With	  data	  obtained	  from	  the	  same	  biological	  condition,	  ProteoMirExpress	  
accepts	  mRNA	  and	  protein	  expression	   levels	   from	  one	  biological	  stage,	  or	  expression	  changes	  
from	  two	  biological	  stages.	  For	  data	  from	  one	  biological	  stage	  in	  one	  file,	  the	  input	  file	  should	  
contain	   three	   columns:	   the	   identifier	   of	   the	   genes,	   the	   corresponding	   expression	   values	   of	  
mRNA	  and	  the	  expression	  values	  of	  the	  proteins.	  Protein	  and	  mRNA	  expression	  data	  can	  also	  be	  
inputted	   in	   two	   files,	   one	   for	   protein	   and	   the	   other	   for	  mRNA.	   Each	   file	   should	   contain	   two	  
columns:	   the	   first	   one	   is	   the	   identifier	   of	   protein	   or	  mRNA	  and	   the	   second	   is	   the	   expression	  
values.	  ProteoMirExpress	  will	  match	  the	  protein	  and	  mRNA	  from	  the	  same	  gene	  for	  the	  users	  if	  
the	   input	   identifies	  are	   in	  different	   types.	  ProteoMirExpress	  can	  recognize	  protein	  and	  mRNA	  
identifiers	   from	   various	   databases,	   such	   as	   RefSeq,	   Ensemble,	  UCSC,	  Uniprot,	   PDB,	   etc.	  With	  
samples	  achieved	  from	  two	  biological	  stages,	  like	  before	  or	  after	  a	  certain	  biological	  treatment,	  
ProteoMirExpress	   accepts	   the	   expression	   fold	   change	   (or	   log2(fold	   change))	   of	   mRNA	   and	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protein	   in	  one	   file	  or	   two	   files	  with	   the	  same	   format	  described	  above.	  ProteoMirExpress	  also	  
considers	  expression	  change	  p-­‐value	   from	  two	  stage	  data	   if	   the	  user	   input	   the	  p-­‐value	   in	   the	  
column	  next	   to	  expression	  change.	  Then	   the	   input	   files	  mentioned	  above	  should	  contain	   five	  
columns	  and	  three	  columns	  respectively.	  The	  expression	  data	  of	  miRNAs	  can	  also	  be	  optionally	  
inputted	   with	   the	   same	   format	   as	   mRNA	   and	   protein.	   Furthermore,	   to	   serve	   more	   users,	  
ProteoMirExpress	  also	  accept	  data	  from	  only	  mRNA	  or	  protein	  for	  the	  analysis.	  
	  
Data	  analysis	  procedure	  
The	  input	  genes	  or	  miRNAs	  will	  be	  classified	  into	  different	  classes	  according	  to	  their	  expression	  
levels	   (or	  changes),	  as	  well	  as	  p-­‐values	   if	  applicable.	  Users	  can	   input	  a	  customized	  expression	  
level	   (or	   change)	   and	   a	   p-­‐value	   cutoff	   for	   gene	   classification.	   For	   example,	   if	   the	   expression	  
change	   cutoff	   is	   1	   (using	   Log2,	   1	  means	   the	   fold	   change	   cutoff	   is	   2	   folds),	   then	   genes	  whose	  
expression	  decreases	   to	   less	   than	  0.5	   fold	   (Log2(expression	   change)	   <	   -­‐1)	  will	   be	   classified	   as	  
“Decreased”	   (D),	  while	  genes	  whose	  expression	  change	   is	  more	   than	  2	   folds	   (Log2(expression	  
change)	   >	   1)	   will	   be	   “Increased”	   (I)	   and	   the	   rest	   will	   be	   “Unchanged”	   (U).	   Genes	   with	   low	  
expression	   or	   expression	   suppression	   in	   either	   protein	   or	   mRNA	   level	   will	   be	   regarded	   as	  
potential	   targets	   of	   miRNA	   for	   further	   analysis.	   If	   the	   p-­‐value	   cutoff	   is	   set	   to	   be	   0.05,	   for	  
example,	  only	  genes	  whose	  p-­‐value	  lower	  than	  0.05	  will	  be	  classified	  as	  significant	  increased	  or	  
decreased	  genes.	   	  
In	   the	   absence	   of	   miRNA	   expression	   information,	   ProteoMirExpress	   will	   calculate	   the	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significance	  of	  overlaps	  between	  the	  potential	  suppressed	  gene	  sets	  and	  the	  predicted	  target	  
genes	  of	  each	  miRNAs	  with	  hypergeometric	  test	  or	  permutation	  test.	  With	  N	  genes	  in	  the	  whole	  
genome,	  m	  genes	  in	  the	  potential	  suppressed	  gene	  set	  (set	  A),	  n	  genes	  that	  are	  the	  predicted	  
target	  genes	  of	  a	  miRNA	  (set	  B),	  and	  k	  genes	  in	  the	  overlap	  of	  gene	  set	  A	  and	  B,	  hypergeometric	  
p-­‐value	  is	  calculated	  by	  Equation	  1.	  
! =    (!! )(!!!!!! )(!!) 	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   (Equation	  1)	  
Permutation	  test	  is	  performed	  by	  randomly	  selecting	  m	  genes	  from	  the	  genome	  1000	  times.	  If	  
the	  selected	  genes	  in	  q	  of	  the	  1000	  times	  have	  more	  than	  k	  genes	  that	  are	  the	  predicted	  targets	  
of	   a	   miRNA,	   the	   permutation	   p-­‐value	   is	   calculated	   by	   ! = !/1000 	   (36).	   The	   cutoff	   of	  
hypergeometric	  and	  permutation	  p-­‐value	  is	  set	  as	  0.05	  by	  default,	  but	  can	  be	  adjusted	  by	  the	  
user.	   	  
In	  the	  presence	  of	  miRNA	  expression	  information,	  the	  targets	  of	  active	  miRNA	  will	  be	  inferred	  
by	   the	   anti-­‐correlation	   between	   the	  miRNA	   expression	   levels	   (or	   changes)	   and	   the	  mRNA	   or	  
protein	   levels	   (or	   changes)	   of	   their	   potential	   targets.	   The	   information	   of	  miRNAs	   is	   collected	  
from	  miRBase	  (37),	  and	  information	  of	  their	  target	  genes	  is	  collected	  from	  multiple	  databases.	  
Computational	   prediction	   databases	   include	   TargetScan	   (6),	  miRanda	   (5),	   PicTar	   (7),	   PITA	   (4)	  
and	   experimental	   databases	   include	   starBase	   (8),	   miRecords	   (9)	   and	   TarBase	   (10).	   starBase	  
contains	   miRNA	   targets	   identified	   by	   high	   throughput	   method	   CLIP/Degradome-­‐seq,	   while	  
miRecords	  and	  TarBase	  contain	  experimental	  verified	  targets.	  To	   integrate	  multiple	  databases	  
from	  heterogenous	  sources,	  we	  use	  an	  Interaction	  Score	  (IS)	  to	  represent	  the	  confidence	  of	  the	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link	  between	  a	  miRNA	  and	  its	  target.	  IS	  is	  calculated	  as	  the	  sum	  of	  weighted	  proportion	  of	  the	  
target	  databases	  containing	  the	  gene	  with	  at	  least	  one	  miRNA	  target	  site	  in	  the	  three	  groups	  of	  
databases	   (21).	   We	   assign	   different	   weights	   for	   the	   three	   different	   groups	   of	   databases	  
according	   to	   reliability,	   with	   experimental	   validated	   targets	   a	   weight	   of	   4,	   high	   throughput	  
methods	  a	  weight	  of	  2,	  and	  computational	  prediction	  a	  weight	  of	  1	  (Equation	  2).	   	  
!" =    !!!∈!! + 2×!!"#$%#!& + 4× !!!∈!! ,	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   (Equation	  2)	  
where	  I	  =	  (TargetScan,	  miRanda,	  PicTar,	  PITA),	  J	  =	  (miRecords,	  TarBase),	  and	   !!=1	  if	  the	  target	  is	  
present	   in	   databases	   I	   or	   J	   and	   !!=0	   otherwise.	   The	   users	   can	   input	   the	   cutoff	   to	   filter	   off	  
targets	  with	  low	  score.	  For	  example,	  if	  cutoff	  is	  0.5,	  then	  only	  targets	  reported	  in	  at	  least	  two	  of	  
four	  computational	  predictions,	  or	  any	  one	  of	  CLIP/Degradome-­‐seq	  database	  and	  experiment	  
collection	  databases,	  will	  be	  selected	  for	  the	  analysis.	   	  
Besides	  of	  direct	  targets,	   indirect	  targets	  of	  each	  miRNA	  are	  further	  predicted.	  When	  miRNAs	  
suppress	   the	  protein	  abundance	  of	  a	  TF,	   targets	  of	   the	  TF	  may	  also	  be	  suppressed	   indirectly.	  
Thus,	  after	  miRNA-­‐targeted	  TFs	  are	  identified,	  the	  promoters	  of	  genes	  with	  suppressed	  mRNA	  
levels	  are	  scanned	  for	  putative	  binding	  sites	  of	  the	  TFs	  with	  the	  method	  described	  by	  Qin	  et	  al.	  
(38).	  Indirect	  targets	  of	  the	  miRNAs	  are	  defined	  as	  genes	  with	  decreased	  mRNA	  abundance	  and	  
putative	  binding	  sites	  of	  miRNA-­‐targeted	  TFs,	  whose	  protein	  abundance	  is	  decreased.	  Users	  can	  
adjust	  several	  parameters	  for	  the	  binding	  site	  scanning,	  including	  the	  size	  of	  promoter	  region,	  
the	   statistical	   p-­‐value	   cutoff	   of	   binding	   site	   significance,	   conservation	   cutoff	   and	   the	   TF	  
information	  sources.	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Output	  
The	   inferred	  miRNA-­‐centered	  regulatory	  network	  will	  be	  visualized	  on	  a	  Cytoscape	  page	   (39).	  
The	  network	  contains	  regulatory	  relationships	  between	  miRNAs	  and	  their	  targets.	  Each	  node	  is	  
a	  miRNA	  or	  a	  target	  gene,	  and	  each	  edge	  is	  an	  arrow	  pointing	  out	  from	  a	  miRNA	  or	  a	  TF	  to	  its	  
target,	  which	   indicates	  the	  miRNA’s	  directly	  or	   indirectly	  suppressing	  regulatory	   function.	  The	  
weights	  of	   the	   lines	  are	  proportional	   to	  the	   IS	  scores	  of	   the	  miRNA-­‐target	  pairs.	  Targets	   from	  
different	   expression	   gene	   classes	   are	   labeled	   in	   different	   colors	   (Figure	   2).	   For	   instance,	   the	  
class	  “UD”,	  which	  is	  colored	  as	  blue	  notes,	  represents	  genes	  that	  have	  mRNA	  levels	  unchanged	  
(U)	  but	  protein	   levels	  decreased	   (D);	  while	  class	  “ML”,	  which	   is	   colored	  as	   light	  purple	  notes,	  
represents	   genes	   with	   medium	   expression	   level	   in	   mRNA	   (M)	   but	   low	   expression	   level	   in	  
protein	  (L).	   	  
On	   the	   second	   tap,	   the	   inferred	   active	   miRNAs	   are	   ranked	   according	   to	   their	   p-­‐values	   in	  
potential	  target	  gene	  set.	  When	  the	  users	  input	  miRNA	  expression	  data,	  the	  server	  will	  report	  
two	   lists	   of	   significant	  miRNAs,	  one	   is	   listed	   in	   the	   “Inputted	  miRNA”	   tap	  which	   contains	   the	  
miRNAs	  that	  have	  high	  expression	  or	  significant	  expression	  changes	  according	  to	  the	  inputted	  
data,	   the	  other	   is	   in	   the	  “All	  enriched	  miRNA”	  tap	  which	  also	   includes	  other	  miRNAs	  that	  are	  
not	  inputted	  miRNAs	  but	  have	  enriched	  target	  genes	  with	  expression	  changes.	  Users	  can	  select	  
a	  sub-­‐group	  of	  miRNAs	  of	  their	  interests	  from	  one	  or	  both	  miRNA	  lists	  to	  redraw	  the	  regulatory	  
network.	  Edges	  between	  a	  miRNA	  from	  “Inputted	  miRNA”	  list	  and	  its	  targets	  will	  be	  shown	  as	  
purple	   lines,	  while	  edges	  between	  other	  enriched	  miRNAs	  and	  their	  targets	  will	  be	  grey	   lines.	  
Indirect	  targets	  are	  also	  shown	  in	  the	  network.	  Arrows	  pointing	  to	  an	  indirect	  target	  are	  in	  sage	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green.	  Click	  on	  a	  miRNA	  node,	  a	  list	  of	  its	  targets	  will	  pop	  up.	  Hovering	  over	  a	  target	  node,	  users	  
can	  find	  its	  inputted	  identifier	  and	  gene	  symbol.	  Click	  on	  it,	  detail	  information	  of	  the	  gene	  will	  
be	  found	  in	  its	  web	  page	  from	  National	  Center	  for	  Biotechnology	  Information	  (NCBI).	  
In	  addition	  to	  targets	  with	  mRNA	  suppressed,	  ProteoMirExpress	  also	  outputs	  targets	  with	  only	  
proteins	  suppressed	  but	  mRNAs	  unchanged.	  MiRNAs,	  enriched	  in	  different	  gene	  sets	  classified	  
according	  to	  mRNA	  and	  protein	   levels,	  can	  be	  viewed	  by	  clicking	  on	  different	  “Type”	  buttons.	  
Click	   on	   each	  miRNA	   in	   the	   network	   or	   tables,	   a	   list	   of	   its	   target	   will	   be	   shown	   in	   a	   pop-­‐in	  
window.	   The	   miRNA-­‐mRNA	   interaction	   site	   information,	   hybridization	   structure	   and	   their	  
sources	   can	   be	   viewed	   by	   clicking	   on	   the	   hyperlinks	   in	   the	   “Interaction”	   and	   “RNAHybrid”	  
columns.	  
Results	  
To	  evaluate	  the	  performance	  of	  ProteoMirExpress,	  we	  run	  several	  example	  tests	  with	  data	  from	  
Baek	  et	  al.	   (35).	   In	   the	   first	  example,	  miR-­‐124	  was	  overexpressed	   in	  Hela	   cell,	   and	   the	  global	  
mRNA	   and	   protein	   expressions	   were	   quantified	   after	   24	   h	   and	   48	   h	   respectively.	   With	   the	  
inputs	   of	   mRNA	   and	   protein	   expression	   profiles,	   and	   miR-­‐124	   as	   the	   known	   miRNA	   with	  
expression	   change,	   ProteoMirExpress	   generates	   a	   list	   of	   predicted	   active	   miRNAs	   and	   their	  
targets	   (Table	   1).	   As	   expected,	   miR-­‐124	   is	   ranked	   on	   the	   top	   with	   the	   most	   significant	  
hypergeometric	   p-­‐value	   (1.19E-­‐15)	   in	   the	   potential	   target	   gene	   set,	   in	   which	   genes	   are	  
down-­‐regulated	   in	   either	   protein	   or	  mRNA	   level.	   According	   to	   protein	   and	  mRNA	   expression	  
changes,	  these	  potential	  targets	  are	  further	  classified	  into	  three	  gene	  sets:	  “DD”	  contains	  genes	  
that	  both	  mRNA	  and	  protein	  are	  down-­‐regulated,	   “UD”	   contains	  genes	   that	  mRNA	   levels	   are	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unchanged	   but	   protein	   levels	   are	   decreased,	   and	   “DU”	   contains	   genes	   that	  mRNA	   levels	   are	  
decreased	  but	  protein	  levels	  are	  unchanged.	  In	  “DD”	  and	  “DU”	  gene	  sets,	  the	  hypergeometric	  
p-­‐values	   of	   miR-­‐124	   also	   rank	   as	   the	   first.	   In	   “UD”,	   even	   though	   miR-­‐124	   is	   not	   the	   most	  
significant	   miRNA,	   the	   targets	   of	   miR-­‐124	   are	   also	   significantly	   enriched.	   Thus,	  
ProteoMirExpress	   is	   able	   to	   find	   not	   only	   targets	  with	   decreased	  mRNA	   abundance	   but	   also	  
those	  whose	  protein	  abundance	  is	  decreased.	   	  
Three	  miR-­‐124-­‐targeted	  TFs,	  SP1,	  TFAP4	  and	  TEAD1,	  are	  found	  to	  have	  predicted	  targets	  whose	  
mRNA	  expressions	  are	  suppressed	  in	  the	  presence	  of	  miR-­‐124	  (Figure	  2).	  Since	  only	  TFs,	  whose	  
protein	  abundance	  is	  decreased,	  will	  be	  analyzed	  to	  predict	  indirect	  targets,	  all	  of	  the	  three	  TFs	  
have	   reduced	  protein	   levels.	  However,	  only	  TEAD1	  has	  mRNA	  significantly	  decreased	  as	  well.	  
The	  mRNA	  abundance	  of	  SP1	  and	  TFAP4	  is	  not	  significantly	  changed	  (92%	  and	  89%	  of	  control	  
respectively),	  even	  though	  their	  protein	  abundance	   is	   less	  than	  50%	  of	  control	   (29%	  and	  43%	  
respectively).	   SP1	   and	   TFAP4	   have	   9	   and	   7	   targets	   in	   the	   miR-­‐124	   controlled	   network	  
respectively,	  which	  indicates	  they	  may	  be	  important	  downstream	  regulators	  for	  the	  function	  of	  
miR-­‐124.	  However,	  these	  TFs	  may	  not	  be	  reported	  as	  miR-­‐124’s	  targets	  by	  other	  tools	  that	  use	  
only	  mRNA	  expression	  data	  for	  the	  analysis.	   	  
Other	  miRNAs	  with	  significantly	  enriched	  targets	  in	  the	  result	  list	  are	  possibly	  functional-­‐related	  
to	  or	  co-­‐expressed	  with	  miR-­‐124	   (Table	   1).	  For	  example,	  hsa-­‐miR-­‐506,	  belonging	  to	  the	  same	  
miRNA	  family,	  has	  very	  similar	  expression	  profiles	  with	  miR-­‐124	  in	  lung	  carcinogenesis	  (40,	  41),	  
as	  well	  as	  breast	  cancer	  samples	   (42).	  And	  miR-­‐124	  is	  known	  as	  a	  neural-­‐specific	  miRNA	  and	  is	  
suppressed	  in	  Huntington’s	  disease,	  while	  hsa-­‐miR-­‐760,	  hsa-­‐miR-­‐432	  and	  hsa-­‐miR-­‐1301	  are	  also	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found	  to	  be	  down-­‐regulated	  in	  the	  same	  disease	   (43).	  The	  miR-­‐Ontology	  Database,	  miRò,	  also	  
reports	  that	  hsa-­‐miR-­‐124,	  hsa-­‐miR-­‐760	  and	  hsa-­‐miR-­‐432	  are	  all	  associated	  to	  brain	  tissues;	  and	  
other	   enriched	   miRNAs,	   such	   as	   hsa-­‐miR-­‐943,	   hsa-­‐miR-­‐548m	   and	   hsa-­‐miR-­‐1301	   etc.,	   are	  
associated	   with	   Alzheimer's	   disease	   (44).	   The	   regulatory	   network	   controlled	   by	   the	   top	   5	  
enriched	  miRNAs	  is	  shown	  in	  Figure	  2.	  More	  enriched	  miRNAs	  are	   listed	   in	  supplementary	   file	  
Table	  S1.	  Both	  hypergeometric	  p-­‐value	  and	  permutation	  p-­‐value	  of	  each	  miRNA	  are	  shown,	  and	  
the	  Pearson’s	  correlation	  coefficient	  between	  two	  p-­‐values	  is	  as	  high	  as	  0.89.	  
To	  further	  test	  the	  performance	  of	  ProteoMirExpress	  in	  inferring	  co-­‐expressed	  miRNA,	  we	  run	  a	  
second	  example,	  in	  which	  miR-­‐223	  was	  knocked	  out	  in	  mouse	  neutrophils,	  and	  the	  mRNA	  and	  
protein	   expression	   were	   quantified	   in	   day	   8	   from	   progenitor	   differentiation	   (35).	   Again,	  
miR-­‐223	  is	  reported	  as	  the	  most	  significantly	  active	  miRNA	  by	  ProteoMirExpress	  with	  the	  inputs	  
of	  mRNA	  and	  protein	  expression	  changes	  (log2(wild	  type/knockout))	  (Table	  S2).	   	   Of	  57	  miRNAs	  
in	   20	   families	   that	   co-­‐expressed	   with	   miR-­‐223,	   44	   miRNAs	   in	   15	   families	   are	   shown	   in	   the	  
significant	  miRNA	  list	  generated	  by	  ProteoMirExpress	  (Table	  S2).	  The	  co-­‐expression	  of	  miRNAs	  
and	   the	   co-­‐occurrence	  of	   targeting	   sites	  on	  3’-­‐UTR	  are	  highly	   correlated	   (p-­‐value	  <2.2E-­‐16	   in	  
Fisher’s	  exact	  test).	  Regulatory	  network	  with	  all	  co-­‐expressed	  miRNAs	  gives	  an	  overview	  on	  the	  
collaborative	   regulation	   of	   these	   miRNAs	   on	   their	   targets	   (Figure	   3).	   It	   can	   be	   seen	   that	  
ProteoMirExpress	   is	   able	   to	   infer	   active	  miRNAs	   in	   a	   biological	   process	   successfully.	   In	   both	  
cases,	  ProteoMirExpress	  finishes	  the	  analyses	  within	  minutes.	  By	  integrating	  protein	  expression	  
data,	   ProteoMirExpress	   takes	   three	   subgroups	   of	   targets	   into	   consideration	   to	   construct	   the	  
miRNA	  centered	  regulatory	  networks,	  which	  provides	  a	  more	  comprehensive	  understanding	  on	  
the	  targets	  and	  regulatory	  functions	  of	  miRNAs.	   	  




Identification	  of	  miRNA	  targets	  and	  construction	  of	  miRNA	  regulatory	  network	  are	  two	  major	  
steps	   in	  studying	  the	  function	  of	  miRNA	   in	  the	  complex	  gene	  regulatory	  system.	  Perturbation	  
on	  the	  expression	  of	  a	  miRNA	   is	  commonly	  used	  to	   infer	   the	   targets	  of	  a	  miRNA.	  Genes	  with	  
significant	  changes	  in	  mRNA	  or	  protein	  levels	  after	  the	  perturbation	  are	  usually	  considered	  as	  
the	  targets	  of	  the	  miRNA.	  However	  in	  our	  first	  case	  study,	  miR-­‐124	  overexpression	  causes	  105	  
genes	  with	  expression	  significantly	  down-­‐regulated,	  but	  only	  56	  of	  them	  are	  direct	  or	   indirect	  
targets	   of	  miR-­‐124.	   This	   leaves	   46%	  of	   the	   down-­‐regulated	   genes	   unexplained.	   Thus	  we	   also	  
report	  other	  miRNAs	  whose	  targets	  are	  enriched	  in	  the	  differentially	  expressed	  gene	  set,	  which	  
provides	   the	   user	   hints	   about	   other	  miRNAs	   that	  may	   co-­‐expressed	  with	   or	   be	   regulated	   by	  
miR-­‐124.	  These	  regulatory	  links	  are	  shown	  as	  grey	  lines	  to	  distinguish	  from	  those	  from	  miR-­‐124	  
(Figure	   2).	  With	   both	   analyses	   on	   input	  miRNAs	   and	   other	   enriched	  miRNAs,	   as	   well	   as	   the	  
prediction	   of	   indirect	   targets,	   ProteoMirExpress	   provides	   a	   more	   complete	   view	   of	   miRNA	  
effects	   on	   the	   suppressed	   genes,	   which	   covers	   92%	   down-­‐regulated	   genes.	   Besides	   of	  
perturbation	   experiments	   of	  miRNAs,	   our	  web	   server	   can	   also	   be	   applied	   to	   other	   biological	  
studies,	   such	   as	   comparison	   between	   different	   developmental	   stages	   or	   disease	   status,	  
inferring	   a	   miRNA-­‐centered	   regulatory	   network	   that	   controls	   the	   gene	   expression	   changes	  
between	  different	  biological	  conditions.	   	  
With	  recent	  development	  of	  high-­‐throughput	  proteomic	  methods,	  such	  as	  SILAC	  (stable	  isotope	  
labeling	   by	   amino	   acids	   in	   cell	   culture)	   (45,	   46),	   PRISM	   (proteomic	   investigation	   strategy	   for	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mammals)	   (47)	   and	   label-­‐free	   quantitative	   methods	   (48),	   researchers	   are	   able	   to	   quantify	  
protein	  expression	  in	  a	   large	  scale.	  More	  and	  more	  high-­‐throughput	  proteomic	  data	  has	  been	  
generated	  to	  study	  a	  variety	  of	  biological	  processes	  (49-­‐55).	  This	  facilitates	  the	  studies	  on	  gene	  
regulation	  at	  posttranscriptional	  level.	  The	  complexity	  of	  miRNA	  function	  mechanism	  makes	  it	  
difficult	   to	   infer	   which	   level	   miRNA	   uses	   to	   control	   each	   individual	   target.	   Integrating	  
high-­‐throughput	   mRNA	   and	   protein	   data	   provides	   an	   opportunity	   to	   solve	   this	   problem.	  
ProteoMirExpress,	  taking	  multiple	  miRNA	  function	  mechanisms	  into	  consideration,	  studies	  the	  
effect	   of	   miRNA	   on	   both	   mRNAs	   and	   proteins.	   ProteoMirExpress	   reports	   not	   only	   miRNA	  
targets	   that	   mRNA	   level	   are	   decreased,	   but	   also	   subgroups	   of	   targets	   whose	   proteins	   are	  
suppressed	  but	  mRNAs	  are	  not	  significantly	  changed	  or	  mRNAs	  are	  decreased	  but	  proteins	  are	  
not	   significantly	   changed,	  which	   is	  made	  possible	   only	  with	   high-­‐throughput	   proteomic	   data.	  
Current	   tools	   commonly	   use	   only	   mRNA	   expression	   data	   to	   construct	   miRNA	   regulatory	  
networks.	   With	   these	   tools	   the	   subgroups	   of	   miRNA	   targets	   with	   proteins	   suppressed	   but	  
mRNAs	   little	  changed	  would	  be	  completely	   lost	   in	  the	  network.	   In	  the	  case	  study	  of	  miR-­‐124,	  
TFs,	   SP1	  and	  TFAP4,	  are	   regulated	  by	  miR-­‐124	  but	   their	  mRNA	  abundance	   is	  not	   significantly	  
changed.	   Without	   proteomic	   data,	   they	   may	   not	   be	   detected	   as	   targets	   of	   miR-­‐124	   in	   the	  
network	  even	  though	  both	  of	  them	  have	  several	  downstream	  targets	  that	  indirectly	  regulated	  
by	  the	  miRNA.	  Moreover,	  when	  a	  TF	  is	  in	  the	  subgroups	  of	  miRNA	  targets	  with	  mRNA	  decreased	  
but	   protein	   little	   affected,	   genes	  with	   putative	   binding	   sites	   of	   this	   TF	  would	   be	   reported	   as	  
indirect	   targets	   of	   miRNAs	   by	   tools	   using	   only	   mRNA	   expression	   data.	   However,	   since	   the	  
protein	  abundance	  of	  the	  TF	  is	  not	  significantly	  change,	  its	  effects	  on	  the	  downstream	  targets	  in	  
the	   reported	   network	   may	   not	   be	   true.	   The	   same	   problem	   would	   also	   occur	   when	   the	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miRNA-­‐regulated	  proteins	  control	  downstream	  pathways,	  which	  lead	  to	  misunderstanding	  the	  
functions	  of	  these	  miRNA-­‐regulated	  proteins	  in	  the	  network.	  
In	   the	   two	   case	   studies	   analyzed	   above,	   out	   of	   51	   direct	   target	   genes	   that	   are	   significantly	  
suppressed	  (either	  mRNA	  is	  less	  than	  67%	  of	  control	  or	  protein	  is	  less	  than	  50%,	  since	  protein	  
level	   is	   measures	   one	   day	   later	   than	   mRNA	   level,	   and	   at	   least	   one	   miR-­‐124	   site)	   by	   the	  
overexpression	   of	   miR-­‐124	   in	   Hela	   cell,	   12	   genes	   (23%)	   are	   suppressed	   in	   both	   mRNA	   and	  
protein	   level,	   9	   genes	   (18%)	  are	   suppressed	   in	  only	  protein	   level	  but	  not	  mRNA	   level	   and	  30	  
genes	   (59%)	  are	   suppressed	   in	  only	  mRNA	   level	  but	  not	  protein	   level.	  While	  out	  of	  35	  direct	  
target	  genes	  that	  are	  significantly	  suppressed	  by	  miR-­‐223	  (either	  mRNA	  in	  miR-­‐223	  knockdown	  
is	  less	  than	  67%	  of	  control	  neutrophil	  cell	  or	  protein	  is	  less	  than	  67%,	  and	  at	  least	  one	  miR-­‐223	  
site),	   6	   genes	   (17%)	   are	   suppressed	   in	   both	   mRNA	   and	   protein	   level,	   24	   genes	   (69%)	   are	  
suppressed	  in	  only	  protein	  level	  but	  not	  mRNA	  level	  and	  5	  genes	  (14%)	  are	  suppressed	  in	  only	  
mRNA	  level	  but	  not	  protein	  level.	  It	  seems	  that	  the	  proportion	  of	  each	  subgroup	  of	  targets	  can	  
be	  different	  for	  different	  miRNAs	  or	  maybe	  different	  cells.	  Data	  collection	  time	  is	  also	  thought	  
to	   affect	   the	   proportion	   of	   different	   subgroups,	   since	   short	   time	   courses	   after	   miRNA	  
perturbation	  but	  before	  deadenylation	  may	  lead	  to	  more	  observations	  of	  “UD”	  group	  (30,	  31,	  
56,	   57).	   On	   the	   other	   hand,	   long	   time	   courses	   after	   miRNA	   perturbation,	   when	   mRNA	  
deadenylation	  and	  decay	  shows	  strong	  effects,	  may	  report	  more	  genes	   from	  “DD”	  group	  (58,	  
59).	  However,	  in	  an	  experiment	  with	  long	  time	  scales,	  where	  the	  miRNA	  effects	  are	  steady,	  less	  
direct	   targets	   but	   more	   indirect	   targets	   will	   be	   detected.	   Thus,	   the	   determination	   of	   data	  
collection	  time	  is	  an	  important	  issue	  in	  miRNA	  targets	  identification	  studies.	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It	   has	   been	   reported	   that	  miRNA	   affected	   target	   gene’s	   expression	   through	   both	   translation	  
inhibition	  and	  RNA	  degradation,	  and	  the	  former	  effect	  is	  relatively	  mild	  compared	  with	  the	  later	  
(32).	   This	   implies	   that	   multiple	   strategies	   are	   used	   by	   miRNA	   to	   refine	   the	   control	   on	   their	  
targets	  in	  a	  quantitative	  manner.	  With	  the	  analysis	  of	  ProteoMirExpress,	  we	  find	  a	  subgroup	  of	  
targets	   whose	   mRNAs	   are	   suppressed	   but	   protein	   levels	   are	   not	   significantly	   changed.	   It	  
indicates	  that	  degradation	  of	  mRNA	  may	  not	  immediately	  suppress	  the	  protein	  level.	  This	  may	  
be	  caused	  by	  the	  low	  protein	  degradation	  rate	  of	  these	  targets.	  Thus	  for	  this	  group	  of	  targets,	  
the	  effect	  of	  miRNA	  seems	   to	  stop	   the	   increase	  of	   their	  protein	   level	  but	  not	   to	   immediately	  
decrease	   them.	   The	   three	   groups	   of	   targets	   detected	   by	   ProteoMirExpress	   demonstrate	   the	  
limitation	   of	   using	   either	   mRNA	   or	   protein	   data	   alone	   to	   study	   the	   effect	   of	   miRNA.	   Either	  
method	  may	  lose	  a	  subgroup	  of	  targets.	  Thus	  with	  the	  integrative	  approach,	  ProteoMirExpress	  
provides	   the	   users	   a	   more	   complete	   and	   detail	   regulatory	   network	   controlled	   by	   miRNAs.	  
Further	   analyses	   on	   the	   functions,	   binding	   site	   sequences	   and	   expression	   details	   of	   different	  
subgroups	  of	  miRNA	  targets	  will	  improve	  our	  understanding	  on	  the	  strategy	  that	  a	  miRNA	  uses	  
to	  preciously	  control	  thousands	  of	  targets.	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Figure	  Legends	  
Figure	   1.	   Overview	   of	   ProteoMirExpress	   workflow.	   A:	   input	   of	   high	   throughput	  mRNA	   and	  
proteomic	   profiling	   data,	   expression	   of	   miRNAs	   input	   is	   optional;	   B:	   data	   analysis	   of	  
ProteoMirExpress;	   C:	   the	   information	   sources	   of	   miRNAtarget;	   D:	   table	   outputs;	   E:	  
miRNA-­‐centered	  posttranscriptional	  regulatory	  network	  andmiRNA-­‐target	  interactions.	  
	  
Figure	   2.miRNA	   regulatory	   network	   with	   the	   top	   10	   enriched	   miRNAs	   in	   Hela	   cells	   with	  
miR-­‐124	  overexpression(p-­‐value	  <	  1E-­‐4).	  Each	  node	  is	  either	  a	  miRNA	  or	  a	  gene.	   	   Each	  edge	  is	  
an	  arrow	  pointing	  out	  from	  a	  miRNA	  to	  its	  target,	  indicating	  its	  suppressing	  role.	  The	  weights	  of	  
the	   lines	   are	   proportional	   to	   the	   IS	   scores	   of	   the	   miRNA-­‐target	   pairs.	   Edges	   in	   purple	   line:	  
connection	   between	   a	  miRNA	   from	   “Inputted	  miRNA”	   list	   and	   its	   targets;	   Edges	   in	   grey	   line:	  
connection	   between	   other	   enriched	  miRNAs	   and	   their	   targets	   Nodes	   in	   blue:	   genes	   in	   “UD”	  
class,	   having	   mRNA	   levels	   unchanged	   (U)	   but	   protein	   levels	   decreased	   (D);	   Nodes	   in	   green:	  
genes	  in	  “ML”	  class,	  having	  medium	  expression	  level	   in	  mRNA	  (M)	  but	  low	  expression	  level	   in	  
protein	  (L).	  Nodes	  in	  pink:	  genes	  in	  “D”	  class,	  having	  decreased	  expression	  in	  mRNA	  or	  protein	  
when	  only	  mRNA	  or	  protein	  data	  is	  inputted	  but	  not	  both.	  
	  
	   Figure	   3.	  miRNA	   regulatory	   network	  with	   the	   co-­‐expressed	  miRNAs	   in	  miR-­‐223	   expressed	  
mouse	  neutrophils.	  Refer	  to	  Figure	  2	  legend	  for	  detail	  description	  of	  the	  graph.	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Figure	  2.	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Table	   1.	   Inferred	   active	   miRNAs	   by	   ProteoMirExpress	   in	   Hela	   cells	   with	   miR-­‐124	  
overexpression	  (p-­‐value	  <	  1E-­‐4).	  
miRNA	  
No.	  of	  













hsa-­‐miR-­‐124	   51	   1.19E-­‐15	   12	   2.04E-­‐08	   9	   1.83E-­‐03	   30	   2.62E-­‐08	  
hsa-­‐miR-­‐506	   46	   4.96E-­‐13	   11	   2.49E-­‐07	   9	   1.28E-­‐03	   26	   2.03E-­‐06	  
hsa-­‐miR-­‐760	   13	   3.09E-­‐06	   3	   5.41E-­‐03	   3	   1.44E-­‐02	   7	   1.82E-­‐03	  
hsa-­‐miR-­‐943	   9	   1.78E-­‐05	   3	   1.01E-­‐03	   2	   3.20E-­‐02	   4	   1.45E-­‐02	  
hsa-­‐miR-­‐548m	   16	   2.19E-­‐05	   5	   3.47E-­‐04	   5	   1.99E-­‐03	   6	   6.31E-­‐02	  
hsa-­‐miR-­‐545	   18	   2.94E-­‐05	   3	   4.21E-­‐02	   5	   5.24E-­‐03	   10	   5.11E-­‐03	  
hsa-­‐miR-­‐525-­‐3p	   7	   4.94E-­‐05	   2	   7.43E-­‐03	   0	   -­‐	   5	   4.21E-­‐04	  
hsa-­‐miR-­‐802	   14	   6.03E-­‐05	   4	   1.99E-­‐03	   3	   4.03E-­‐02	   7	   1.49E-­‐02	  
hsa-­‐miR-­‐1252	   16	   1.15E-­‐04	   5	   6.69E-­‐04	   6	   5.45E-­‐04	   5	   1.50E-­‐01	  
hsa-­‐miR-­‐432	   14	   1.17E-­‐04	   2	   1.05E-­‐01	   5	   1.38E-­‐03	   7	   1.98E-­‐02	  
hsa-­‐miR-­‐564	   5	   1.48E-­‐04	   1	   6.58E-­‐02	   1	   9.12E-­‐02	   3	   4.33E-­‐03	  
hsa-­‐miR-­‐323b-­‐5p	   10	   2.50E-­‐04	   2	   4.52E-­‐02	   3	   1.30E-­‐02	   5	   2.27E-­‐02	  
hsa-­‐miR-­‐513c	   10	   4.32E-­‐04	   3	   5.90E-­‐03	   2	   8.99E-­‐02	   5	   2.89E-­‐02	  
hsa-­‐miR-­‐544	   30	   4.46E-­‐04	   6	   1.50E-­‐02	   6	   6.47E-­‐02	   18	   1.21E-­‐02	  
hsa-­‐miR-­‐548p	   18	   5.42E-­‐04	   4	   1.69E-­‐02	   5	   1.36E-­‐02	   9	   4.25E-­‐02	  
hsa-­‐miR-­‐922	   13	   5.53E-­‐04	   2	   1.10E-­‐01	   2	   1.73E-­‐01	   9	   2.65E-­‐03	  
hsa-­‐miR-­‐1301	   10	   6.76E-­‐04	   2	   5.64E-­‐02	   2	   9.83E-­‐02	   6	   1.11E-­‐02	  
hsa-­‐miR-­‐518b	   5	   7.05E-­‐04	   1	   9.08E-­‐02	   2	   8.42E-­‐03	   2	   7.02E-­‐02	  
hsa-­‐miR-­‐1197	   8	   7.33E-­‐04	   4	   1.26E-­‐04	   3	   6.30E-­‐03	   1	   3.55E-­‐01	  
hsa-­‐miR-­‐518c*	   6	   7.37E-­‐04	   0	   -­‐	   2	   1.85E-­‐02	   4	   5.40E-­‐03	  
hsa-­‐miR-­‐381	   33	   7.81E-­‐04	   6	   3.07E-­‐02	   8	   2.08E-­‐02	   19	   2.58E-­‐02	  
hsa-­‐miR-­‐765	   11	   8.46E-­‐04	   4	   1.22E-­‐03	   3	   2.95E-­‐02	   4	   1.31E-­‐01	  
hsa-­‐miR-­‐1227	   6	   8.75E-­‐04	   1	   1.37E-­‐01	   1	   1.82E-­‐01	   4	   6.05E-­‐03	  
hsa-­‐miR-­‐1266	   8	   9.01E-­‐04	   1	   2.19E-­‐01	   2	   5.50E-­‐02	   5	   9.63E-­‐03	  
hsa-­‐miR-­‐661	   8	   9.66E-­‐04	   3	   2.57E-­‐03	   3	   7.10E-­‐03	   2	   2.44E-­‐01	  
*Gene	   classes	   “DD”	   contains	   genes	   that	   both	   mRNA	   and	   protein	   are	   down-­‐regulated,	   “UD”	  
contains	   genes	   that	  mRNA	   levels	   are	   unchanged	   but	   protein	   levels	   are	   decreased,	   and	   “DU”	  
contains	  genes	  that	  mRNA	  levels	  are	  decreased	  but	  protein	  levels	  are	  unchanged.	  
	  
